Roivant Sciences Ltd.
ROIV
Classificação em ações
#979
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Preço da ação
$33.73
Última sincronização: 2026-07-31
Valor de mercado
$24.37B
Variação (1 dia)
-2.28%
Variação (1 ano)
95.44%
País
GB
Negociar Roivant Sciences Ltd. (ROIV)
Categoria
Healthcare
EPS de Roivant Sciences Ltd. (ROIV)
EPS em June 2026 TTM: $-0.38
De acordo com os últimos relatórios financeiros e o preço das ações da Roivant Sciences Ltd., o EPS atual da empresa (TTM) é $-0.38. No final de 2024, a empresa teve um EPS de $5.55, um aumento em relação a ao EPS de 2023, que foi de $-1.42.
Histórico de EPS da Roivant Sciences Ltd. de 2020 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $-0.38 | 58.33% |
| 2025 | $-0.24 | -104.32% |
| 2024 | $5.55 | -490.85% |
| 2023 | $-1.42 | 12.70% |
| 2022 | $-1.26 | 6.78% |
| 2021 | $-1.18 | -167.43% |
| 2020 | $1.75 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $17.32 | -4,657.89% |
US
|
|
| $-7.98 | 2,000.00% |
US
|
|
| $-5.29 | 1,292.11% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -7,400.00% |
NL
|
